Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Pediatric Ophthalmology and Strabismus
|
March 1, 1995
Pseudohypopyon in acute myelogeneous leukemia
A Ells, W N Clarke, L P Noel
Eye (London, England)
|
June 26, 2004
Severe retinopathy of prematurity: longitudinal observation of disease and screening implications
A Ells, M Hicks, M Fielden, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
June 1, 1995
The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants
D R Jordan, L H Allen, A Ells, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 1, 1995
Vicryl-mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model
D R Jordan, A Ells, S Brownstein, et al.
Eye (London, England)
|
July 29, 2017
An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials
B W Fleck, C Williams, E Juszczak, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Pediatric Ophthalmology and Strabismus
|
March 1, 1995
Pseudohypopyon in acute myelogeneous leukemia
A Ells, W N Clarke, L P Noel
Eye (London, England)
|
June 26, 2004
Severe retinopathy of prematurity: longitudinal observation of disease and screening implications
A Ells, M Hicks, M Fielden, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
June 1, 1995
The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants
D R Jordan, L H Allen, A Ells, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
August 1, 1995
Vicryl-mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model
D R Jordan, A Ells, S Brownstein, et al.
Eye (London, England)
|
July 29, 2017
An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials
B W Fleck, C Williams, E Juszczak, et al.
Page
of 1